Spectrum Therapeutics, the medical division of Canopy Growth (TSX:WEED; NYSE:CGC) appointed Dr. Marcel Bonn-Miller as global clinical scientific director.
MediPharm Labs (TSXV:LABS; OTCQB:MEDIF) appointed Braden Fenske as chief strategy officer and Dr. Paul Tam to its board of directors, effective immediately.